Document Detail


Acute presentation of vascular disease within the orbit-a descriptive synopsis of mechanisms.
MedLine Citation:
PMID:  23370421     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Vascular events in the orbit can present with an acute onset of symptoms, and, if untreated, raised orbital pressure and reduced arterial perfusion can lead to loss of orbital functions. Such events are commonly due to haemorrhage, but can also be due to arterio-venous shunts and very rarely arise from intraorbital vascular occlusion. The likely diagnosis is often evident on taking a thorough history and examination and in most cases, after appropriate imaging, the process can be monitored for progression. Visual failure is usually due to high pressure at the orbital apex, resulting in ischaemic optic neuropathy, and any evidence of a persistent significant visual impairment should prompt intervention.
Authors:
G E Rose; D H Verity
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2013-02-01
Journal Detail:
Title:  Eye (London, England)     Volume:  27     ISSN:  1476-5454     ISO Abbreviation:  Eye (Lond)     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-03-14     Completed Date:  2013-08-02     Revised Date:  2014-03-06    
Medline Journal Info:
Nlm Unique ID:  8703986     Medline TA:  Eye (Lond)     Country:  England    
Other Details:
Languages:  eng     Pagination:  299-307     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Arteriovenous Malformations / diagnosis*
Hemangioma / diagnosis*
Humans
Lymphangioma / diagnosis*
Orbit / blood supply*
Orbital Neoplasms / diagnosis*
Peripheral Vascular Diseases / diagnosis*
Retrobulbar Hemorrhage / diagnosis*
Varicose Veins
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Eye casualty services in London.
Next Document:  The burden of metastatic melanoma: treatment patterns, healthcare use (utilization), and costs.